Group I mGluR ligands fail to affect 6-hydroxydopamine-induced death and glutamate release of PC12 cells

Acta Pharmacologica Sinica

Volumn 24, Issue 7, 2003, Pages 641-645+724

  Li, Hao ^a   Ding, J H Jian Hua ^a   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

6 hydroxydopamine; Cell survival; Excitatory amino acid agonist; Excitatory amino acid antagonist; Glutamic acid; Metabotropic glutamate receptors; PC 12 cells

Indexed keywords

2 AMINO 3 PHOSPHONOPROPIONIC ACID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3,5 DIHYDROXYPHENYLGLYCINE; 6 HYDROXYTRYPTAMINE; DNA FRAGMENT; GLUTAMIC ACID; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROSCOPY; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; TIME;

ADRENERGIC AGENTS; ALANINE; ANIMALS; APOPTOSIS; CELL SURVIVAL; DNA FRAGMENTATION; DRUG INTERACTIONS; GLUTAMIC ACID; LIGANDS; METHOXYHYDROXYPHENYLGLYCOL; OXIDOPAMINE; PC12 CELLS; RATS; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0038729640     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cartmell J, Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 2000; 75: 889-907.
2. Wittmann M, Marino MJ, Conn PJ. Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. J Pharmacol Exp Ther 2002; 302: 433-41.
3. Shimazoe T, Doi Y, Aria I, Yoshimatsu A, Fukumono T, Watanabe S. Both metabotropic glutamate I and II receptors mediated augmentation of dopamine release from the striatum in methamphetamine-sensitized rats. Jpn J Pharmacol 2002; 89: 85-8.
4. Blum D, Wu Y, Nissou MF, Arnaud S, Benabid AL, Verna JM. P53 and Bax activation in 6-OHDA-induced apoptosis in PC12 cells. Brain Res 1997; 751: 139-42.
5. He Y, Lee T, Leong SK. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra. Brain Res 2000; 858: 163-6.
6. Spooren WP, Gasparini F, Bergmann R, Kuhn R. Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur J Pharmacol 2000; 406: 403-10.
7. Kane MD, Vanden Heuvel JP, Isom GE, Schwarz RD. Differential expression of group I metabotropic glutamate receptors (mGluRs) in the rat pheochromocytoma cell line PC12: role of nerve growth factor and ras. Neurosci Lett 1998; 252: 1-4.
8. Kalda A, Kaasik A, Vassiljev V, Pokk P, Zharkovsky A. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res 2000; 853: 370-3.
9. Bruno V, Battaglia G, Kingston A, O'Neill MJ, Catania MV, Di Grezia R, et al. Neuroprotective activity of the potent and selective mGlula metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology 1999; 38: 199-207.
10. Aguirre JA, Andbjer B, Gonzalez-Baron S, Hansson A, Stromberg I, Agnati LF, et al. Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury. Neuroreport 2001; 12: 2615-7.